Guidelines for Care of Adults With Steven-Johnson Syndrome, Toxic Epidermal Necrolysis
Evidence-based guidelines address supportive care treatment options for adult patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Stevens-Johnson Syndrome
Bacteremia Risk in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Prediction of sepsis via markers such as hypothermia and elevated procalcitonin
may allow for its early detection and management.
Unique Presentation of SJS in a Female Patient Treated With TMP-SMX
The patient, who presented to the clinical office complaining of dysuria, was diagnosed with a urinary tract infection and was prescribed TMP-SMX.
Antiepileptic Drugs Associated With Significant Risk for Stevens-Johnson Syndrome, TEN
The voluntary nature of FAERS reporting can lead to both underreporting and the Weber effect, which is a decline in reports of adverse events in the 2 years after a drug appears on the market.
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Causes, Treatment Investigated
The multicenter retrospective study (N=377) was conducted to investigate the causes, treatment protocols, and mortality rates of US adults with SJS/TEN.
Case Report: Do Maternal Stevens-Johnson Syndrome Causative Agents Transfer to Newborn?
A case reports on a newborn with congenital toxoplasmosis who was safely and successfully treated with agents that caused Stevens-Johnson syndrome (SJS) in the mother.
Stevens Johnson Syndrome Linked to Sleep Disorder Treatment
A patient developed Stevens-Johnson Syndrome shortly after using armodafinil for a sleep disorder.
